Fibrolamellar hepatocellular carcinoma
Other Names for this Disease
- Eosinophilic glassy cell hepatoma
- Eosinophilic hepatocellular carcinoma with lamellar fibrosis
- Fibrolamellar carcinoma
- Fibrolamellar oncocytic hepatoma
- Fibrolamellar variant of hepatocellular carcinoma
- ClinicalTrials.gov lists trials that are studying or have studied Fibrolamellar hepatocellular carcinoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
(Bayer HealthCare Pharmaceuticals)
The FDA has approved this product to be used in this manner.
|Treatment of unresectable hepatocellular carcinoma|
|More Information about this product||Drug Information Portal|